| Title | Author | Year | SCOPUS | PUBMED | ISI | TCI | |
|---|---|---|---|---|---|---|---|
| 1. | Selective cyclooxygenase-2 inhibition: a target in cancer prevention and treatment. | Subongkot, S. | 2003 | ||||
| 2. | Exploration of pain management following implementation of WHO pain guidelines | S. Subongkot S. Khounnikhom N. Pratheepawanit Johns A. Sookprasert |
2007 | ||||
| 3. | Exploration the Results of Cancer Pain Management Following Implementation of World Health Organization (WHO) Pain Guideline | Suphat Subongkot Sugunya Khounnikhom Nutjaree Pratheepawanit Johns Aunkhae Sookprasert |
2008 | ||||
| 4. | Randomized, single-blind, crossover trial comparing the antiemetic effect of tropisetron or generic ondasetron plus corticosteriods in patients receiving high dose cisplatin-containing chemotherapy | S. Subongkot Y. Payanta A. Sookprasert |
2008 | ||||
| 5. | Drug interactions in cancer treatment: A potential role for oncology pharmacists | Subongkot, S. | 2009 | ||||
| 6. | Outcome of Chemotherapy Counseling in Oncology Patients by Pharmacist | Suphat Subongkot Siriwan Srisawat Nutjaree Pratheepawanit Johns Aunkhae Sookprasert |
2009 | ||||
| 7. | An exploratory analysis of cisplatin-induced nephrotoxicity and ototoxicity in cancer patients with solid tumors. | S. Subongkot | 2010 | ||||
| 8. | Cytotoxics in the pipeline: Carrier-mediated anticancer agents in development | Subongkot, S. | 2011 | ||||
| 9. | Drug interactions in oncology: The impact on cancer care | Subongkot, S. | 2011 | ||||
| 10. | Cachexia: A Review of Therapeutic and Management | Suphat Subongkot Thailand. Khon Kaen Kittipong Onseng |
2012 | ||||
| 11. | Drug Use Review of Olanzapine for Psychiatric Outpatients at Srinagarind Hospital | Suthan Chanthawong Pattharee Paholpak Samai Junnamom Suphat Subongkot Denpong Patthanasetthanon Wilaiwan Boontawee Amornrat Shoora Suchat Paholpak |
2012 | ||||
| 12. | Serum melatonin levels and antioxidant capacities after consumption of pineapple, orange, or banana by healthy male volunteers | Sae-Teaw, M Johns, J Johns, NP Subongkot, S |
2013 | ||||
| 13. | A phase II randomized, double-blind placebo-controlled trial of an antiemetic, 6-gingerol in solid tumor patients receiving moderately to highly emetogenic adjuvant chemotherapy. | Jitprapa Konmun Kwanjit Danwilai Nuttapong Ngamphaiboon Aumkhae Sookprasert Ekaphop Sirachainan Suphat Subongkot |
2014 | ||||
| 14. | Effectiveness of olanzapine for the treatment of breakthrough chemotherapy induced nausea and vomiting | Chanthawong, S Subongkot, S Sookprasert, A |
2014 | ||||
| 15. | คุณภาพชีวิตของผู้ป่วยมะเร็งเต้านมระยะต้นและระยะลุกลาม | สุภัสร์ สุบงกช นุจรี ประทีปปะวณิช จอห์นส อรไพลิน เผื่อนพินิจ หทัยกาญจน์ สายทรัพย์ กัญญาณัฐ เนตรสถิตย์ |
2014 | ||||
| 16. | Evaluation of Chemotherapy Contamination Following the Implementation of Closed System Transfer Devices | Warunsuda Sripakdee Suphat Subongkot Wannaporn Wattanawong Saroch Onlaor |
2015 | ||||
| 17. | ASSOCIATION BETWEEN HIGH PINEAL FLUORIDE CONTENT AND PINEAL CALCIFICATION IN A LOW FLUORIDE AREA | Trai Tharnpanich Jeffrey Johns Suphat Subongkot Nutjaree Pratheepawanit Johns Amnat Kitkhuandee Yanyong Toomsan Somkiat Luengpailin |
2016 | ||||
| 18. | Hospitalization and cost after switching from atypical to typical antipsychotics in schizophrenia patients in Thailand | Boonlue, T Subongkot, S Dilokthornsakul, P Kongsakon, R Pattanaprateep, O Suanchang, O Chaiyakunapruk, N |
2016 | ||||
| 19. | Off-label use and pharmacovigilance among infants: analysis of the Thai Health Product Vigilance National Database | Subongkot, S. Chaiyakunapruk, N. |
2016 | ||||
| 20. | Antioxidant activity of ginger extract as a daily supplement in cancer patients receiving adjuvant chemotherapy: a pilot study. | Kwanjit Danwilai Jitprapa Konmun Bung-orn Sripanidkulchai Suphat Subongkot |
2017 | ||||
| 21. | A phase II randomized double-blind placebo-controlled study of 6-gingerol as an anti-emetic in solid tumor patients receiving moderately to highly emetogenic chemotherapy | Konmun, J Danwilai, K Ngamphaiboon, N Sripanidkulchai, B Sookprasert, A Subongkot, S |
2017 | ||||
| 22. | Beneficial Effects of Adjuvant Melatonin in Minimizing Oral Mucositis Complications in Head and Neck Cancer Patients Receiving Concurrent Chemoradiation | Onseng, K Johns, NP Khuayjarernpanishk, T Subongkot, S Priprem, A Hurst, C Johns, J |
2017 | ||||
| 23. | Comparative efficacy and safety of pharmacologic interventions for cachexia: A systematic review and network meta-analysis | M. Sae-Teaw S. Subongkot N. Chaiyakunapruk |
2017 | ||||
| 24. | Translation and validation of the Thai version of Family Reported Outcome Measure (Thai FROM-16VC) in Thai family members of cancer patients | S. Subongkot P. Chantarasap N. P. Johns S. Pairojkul A. Sookprasert |
2017 | ||||
| 25. | Cost-effectiveness analysis of olanzapine-containing antiemetic therapy for managing highly emetogenic chemotherapy in Southeast Asia: a multinational study | Chanthawong, S Lim, YH Subongkot, S Chan, A Andalusia, R Ahmad Bustamam, RS Chaiyakunapruk, N |
2019 | ||||
| 26. | Validation of the Thai version of the family reported outcome measure (FROM-16)(c) to assess the impact of disease on the partner or family members of patients with cancer | Pattariya Chantarasap Nutjaree Pratheepawanit Johns Srivieng Pairojkul Aumkhae Sookprasert Kosin Wirasorn Areewan Cheawchanwattana Sam Salek Suphat Subongkot |
2019 | ||||
| 27. | Validation of the Thai version of the family reported outcome measure (FROM-16)© to assess the impact of disease on the partner or family members of patients with cancer. | Johns, N.P. Pairojkul, S. Sookprasert, A. Wirasorn, K. Cheawchanwattana, A. Subongkot, S. |
2019 | ||||
| 28. | Doripenem Pharmacokinetics in Hemodialysis | Chaiyakum, A. Subongkot, S. Aromdee, C. Jaisue, S. |
2020 | ||||
| 29. | HLA-DRB1*07:01 and lapatinib-induced hepatotoxicity: a systematic review and meta-analysis | Tangamornsuksan, W Kongkaew, C Scholfield, CN Subongkot, S Lohitnavy, M |
2020 | ||||
| 30. | U.S.-Thai Consortium for the development of pharmacy education in Thailand: History, progress, and impact | Nathisuwan, S. Pattharachayakul, S. Subongkot, S. Doungngern, T. Jones, S.M. Engle, J.P. Lau, A. Katz, M.D. Moreton, J.E. Ryan, M. |
2020 | ||||
| 31. | An Exploration of Heart Failure Risk in Breast Cancer Patients Receiving Anthracyclines with or without Trastuzumab in Thailand: A Retrospective Study | Yoodee, J Sookprasert, A Sanguanboonyaphong, P Chanthawong, S Seateaw, M Subongkot, S |
2021 | ||||
| 32. | Efficacy and safety of pharmacological cachexia interventions: Systematic review and network meta-analysis | Manit Saeteaw Phitjira Sanguanboonyaphong Jukapun Yoodee Kaitlyn Craft Ratree Sawangjit Nuttapong Ngamphaiboon Prapimporn Chattranukulchai Shantavasinkul Suphat Subongkot Nathorn Chaiyakunapruk |
2021 | ||||
| 33. | Predictors of Chemotherapy Induced Adverse Events in Pediatric Osteosarcoma Patients. | Komvilaisak, P. , Chanthawong, S. Subongkot, S. |
2022 | ||||
| 34. | Using an online journal club to improve Asian speakers’ comfort in using English to discuss and understand research papers written in English | Tsuchiya, M Saeteaw, M Subongkot, S Tharnpanich, T Konmun, J Nasu, I Shimanuki, Y Tsuchitani, T Ezura, M Hashiguchi, K Bryan, JC Kawazoe, H |
2022 | ||||
| 35. | Trends in Anticoagulant Utilization and Clinical Outcomes for Cancer-Associated Thrombosis: A Multicenter Cohort Study in Thailand's Upper-Middle-Income Country Setting. | Kengkla, K Nathisuwan, S Sripakdee, W Saelue, P Sengnoo, K Sookprasert, A Subongkot, S |
2024 | Count | 19 | 14 | 19 | 6 |
| Title | Authors | Year | Publication name | Cited count | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| < 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Total | ||||||
| 1. | Selective cyclooxygenase-2 inhibition: A target in cancer prevention and treatment | Subongkot, S. | 2003 |
Pharmacotherapy 1 (23), pp. 9-28 |
||||||||
| 2. | Drug interactions in cancer treatment: A potential role for oncology pharmacists | Subongkot, S. | 2009 |
European Journal of Oncology Pharmacy 2 (3), pp. 8-9 |
||||||||
| 3. | Cytotoxics in the pipeline: Carrier-mediated anticancer agents in development | Subongkot, S. | 2011 |
European Journal of Oncology Pharmacy 2 (5), pp. 28-29 |
||||||||
| 4. | Drug interactions in oncology: The impact on cancer care | Subongkot, S. | 2011 |
European Journal of Oncology Pharmacy 1 (5), pp. 18-19 |
||||||||
| 5. | Serum melatonin levels and antioxidant capacities after consumption of pineapple, orange, or banana by healthy male volunteers | Johns, J.R. Johns, N.P. Subongkot, S. |
2013 |
Journal of Pineal Research 1 (55), pp. 58-64 |
||||||||
| 6. | Effectiveness of olanzapine for the treatment of breakthrough chemotherapy induced nausea and vomiting | Chanthawong, S. Subongkot, S. Sookprasert, A. |
2014 |
Journal of the Medical Association of Thailand 3 (97), pp. 349-355 |
||||||||
| 7. | Hospitalization and cost after switching from atypical to typical antipsychotics in schizophrenia patients in Thailand | Subongkot, S. Chaiyakunapruk, N. |
2016 |
ClinicoEconomics and Outcomes Research (8), pp. 127-136 |
||||||||
| 8. | Off-label use and pharmacovigilance among infants: analysis of the Thai Health Product Vigilance National Database | Subongkot, S. Chaiyakunapruk, N. |
2016 |
Drugs and Therapy Perspectives 7 (32), pp. 304-310 |
||||||||
| 9. | Antioxidant activity of ginger extract as a daily supplement in cancer patients receiving adjuvant chemotherapy: A pilot study | Subongkot, S. | 2017 |
Cancer Management and Research (9), pp. 11-18 |
||||||||
| 10. | A phase II randomized double-blind placebo-controlled study of 6-gingerol as an anti-emetic in solid tumor patients receiving moderately to highly emetogenic chemotherapy | Sookprasert, A. Subongkot, S. |
2017 |
Medical Oncology 4 (34), pp. |
||||||||
| 11. | Beneficial Effects of Adjuvant Melatonin in Minimizing Oral Mucositis Complications in Head and Neck Cancer Patients Receiving Concurrent Chemoradiation | Johns, N.P. Subongkot, S. Priprem, A. Hurst, C.P. Johns, J.R. |
2017 |
Journal of Alternative and Complementary Medicine 12 (23), pp. 957-963 |
||||||||
| 12. | Cost-effectiveness analysis of olanzapine-containing antiemetic therapy for managing highly emetogenic chemotherapy in Southeast Asia: a multinational study | Chanthawong, S. Subongkot, S. Chaiyakunapruk, N. |
2019 |
Supportive Care in Cancer 3 (27), pp. 1109-1119 |
||||||||
| 13. | Validation of the Thai version of the family reported outcome measure (FROM-16)© to assess the impact of disease on the partner or family members of patients with cancer | Johns, N.P. Pairojkul, S. Sookprasert, A. Wirasorn, K. Cheawchanwattana, A. Subongkot, S. |
2019 |
Health and Quality of Life Outcomes 1 (17), pp. |
||||||||
| 14. | Doripenem pharmacokinetics in hemodialysis | Chaiyakum, A. Subongkot, S. Aromdee, C. Jaisue, S. |
2020 |
Infectious Diseases in Clinical Practice 4 (28), pp. 216-222 |
||||||||
| 15. | HLA-DRB1*07:01 and lapatinib-induced hepatotoxicity: a systematic review and meta-analysis | Subongkot, S. | 2020 |
Pharmacogenomics Journal 1 (20), pp. 47-56 |
||||||||
| 16. | U.S.-Thai Consortium for the development of pharmacy education in Thailand: History, progress, and impact | Nathisuwan, S. Pattharachayakul, S. Subongkot, S. Doungngern, T. Jones, S.M. Engle, J.P. Lau, A. Katz, M.D. Moreton, J.E. Ryan, M. |
2020 |
JACCP Journal of the American College of Clinical Pharmacy 5 (3), pp. 935-946 |
||||||||
| 17. | Efficacy and safety of pharmacological cachexia interventions: Systematic review and network meta-analysis | Subongkot, S. Chaiyakunapruk, N. |
2021 |
BMJ Supportive and Palliative Care 1 (11), pp. 75-85 |
||||||||
| 18. | Predictors of Chemotherapy Induced Adverse Events in Pediatric Osteosarcoma Patients | Komvilaisak, P. , Chanthawong, S. Subongkot, S. |
2022 |
Asian Pacific Journal of Cancer Prevention 1 (23), pp. 93-100 |
||||||||
| 19. | Using an online journal club to improve Asian speakers’ comfort in using English to discuss and understand research papers written in English | Subongkot, S. | 2022 |
Journal of Oncology Pharmacy Practice (), pp. |
||||||||
| Title | Authors | Year | Journal title | ||
|---|---|---|---|---|---|
| 1. | Selective cyclooxygenase-2 inhibition: a target in cancer prevention and treatment. | Subongkot, S Frame, D Leslie, W Drajer, D |
2003 |
Pharmacotherapy 1 (23), pp. 9-28 |
|
| 2. | Serum melatonin levels and antioxidant capacities after consumption of pineapple, orange, or banana by healthy male volunteers. | Sae-Teaw, M Johns, J Johns, NP Subongkot, S |
2013 |
Journal of pineal research 1 (55), pp. 58-64 |
|
| 3. | Effectiveness of olanzapine for the treatment of breakthrough chemotherapy induced nausea and vomiting. | Chanthawong, S Subongkot, S Sookprasert, A |
2014 |
Journal of the Medical Association of Thailand = Chotmaihet thangphaet 3 (97), pp. 349-55 |
|
| 4. | Hospitalization and cost after switching from atypical to typical antipsychotics in schizophrenia patients in Thailand. | Boonlue, T Subongkot, S Dilokthornsakul, P Kongsakon, R Pattanaprateep, O Suanchang, O Chaiyakunapruk, N |
2016 |
ClinicoEconomics and outcomes research : CEOR (8), pp. 127-36 |
|
| 5. | Antioxidant activity of ginger extract as a daily supplement in cancer patients receiving adjuvant chemotherapy: a pilot study. | Danwilai, K Konmun, J Sripanidkulchai, BO Subongkot, S |
2017 |
Cancer management and research (9), pp. 11-18 |
|
| 6. | A phase II randomized double-blind placebo-controlled study of 6-gingerol as an anti-emetic in solid tumor patients receiving moderately to highly emetogenic chemotherapy. | Konmun, J Danwilai, K Ngamphaiboon, N Sripanidkulchai, B Sookprasert, A Subongkot, S |
2017 |
Medical oncology (Northwood, London, England) 4 (34), pp. 69 |
|
| 7. | Beneficial Effects of Adjuvant Melatonin in Minimizing Oral Mucositis Complications in Head and Neck Cancer Patients Receiving Concurrent Chemoradiation. | Onseng, K Johns, NP Khuayjarernpanishk, T Subongkot, S Priprem, A Hurst, C Johns, J |
2017 |
Journal of alternative and complementary medicine (New York, N.Y.) 12 (23), pp. 957-963 |
|
| 8. | Validation of the Thai version of the family reported outcome measure (FROM-16)© to assess the impact of disease on the partner or family members of patients with cancer. | Chantarasap, P Johns, NP Pairojkul, S Sookprasert, A Wirasorn, K Cheawchanwattana, A Salek, S Subongkot, S |
2019 |
Health and quality of life outcomes 1 (17), pp. 32 |
|
| 9. | Cost-effectiveness analysis of olanzapine-containing antiemetic therapy for managing highly emetogenic chemotherapy in Southeast Asia: a multinational study. | Chanthawong, S Lim, YH Subongkot, S Chan, A Andalusia, R Ahmad Bustamam, RS Chaiyakunapruk, N |
2019 |
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 3 (27), pp. 1109-1119 |
|
| 10. | HLA-DRB1*07:01 and lapatinib-induced hepatotoxicity: a systematic review and meta-analysis. | Tangamornsuksan, W Kongkaew, C Scholfield, CN Subongkot, S Lohitnavy, M |
2020 |
The pharmacogenomics journal 1 (20), pp. 47-56 |
|
| 11. | An Exploration of Heart Failure Risk in Breast Cancer Patients Receiving Anthracyclines with or without Trastuzumab in Thailand: A Retrospective Study. | Yoodee, J Sookprasert, A Sanguanboonyaphong, P Chanthawong, S Seateaw, M Subongkot, S |
2021 |
Clinics and practice 3 (11), pp. 484-493 |
|
| 12. | Predictors of Chemotherapy Induced Adverse Events in Pediatric Osteosarcoma Patients. | Sanguanboonyaphong, P Komvilaisak, P Suwannaying, K Yoodee, J Saeteaw, M Chanthawong, S Subongkot, S |
2022 |
Asian Pacific journal of cancer prevention : APJCP 1 (23), pp. 93-100 |
|
| 13. | Using an online journal club to improve Asian speakers' comfort in using English to discuss and understand research papers written in English. | Tsuchiya, M Saeteaw, M Subongkot, S Tharnpanich, T Konmun, J Nasu, I Shimanuki, Y Tsuchitani, T Ezura, M Hashiguchi, K Bryan, JC Kawazoe, H |
2022 |
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (), pp. 10781552221107548 |
|
| 14. | Trends in Anticoagulant Utilization and Clinical Outcomes for Cancer-Associated Thrombosis: A Multicenter Cohort Study in Thailand's Upper-Middle-Income Country Setting. | Kengkla, K Nathisuwan, S Sripakdee, W Saelue, P Sengnoo, K Sookprasert, A Subongkot, S |
2024 |
JCO global oncology (10), pp. e2300353 |
| Title | Authors | Year | Journal title | Cited count | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| < 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Total | ||||||
| 1. | Selective cyclooxygenase-2 inhibition: A target in cancer prevention and treatment | S Subongkot D Frame W Leslie D Drajeeer |
2003 |
PHARMACOTHERAPY 1.0 (23.0), pp. 9.0-28.0 |
30 | 0 | 0 | 0 | 0 | 0 | 30 | |
| 2. | Exploration of pain management following implementation of WHO pain guidelines | S. Subongkot S. Khounnikhom N. Pratheepawanit Johns A. Sookprasert |
2007 |
JOURNAL OF CLINICAL ONCOLOGY 18.0 (25.0), pp. |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 3. | Randomized, single-blind, crossover trial comparing the antiemetic effect of tropisetron or generic ondasetron plus corticosteriods in patients receiving high dose cisplatin-containing chemotherapy | S. Subongkot Y. Payanta A. Sookprasert |
2008 |
JOURNAL OF CLINICAL ONCOLOGY 15.0 (26.0), pp. |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 4. | An exploratory analysis of cisplatin-induced nephrotoxicity and ototoxicity in cancer patients with solid tumors. | S. Subongkot | 2010 |
JOURNAL OF CLINICAL ONCOLOGY 15.0 (28.0), pp. |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 5. | Serum melatonin levels and antioxidant capacities after consumption of pineapple, orange, or banana by healthy male volunteers | Manit Sae-Teaw Jeffrey Johns Nutjaree Pratheepawanit Johns Suphat Subongkot |
2013 |
JOURNAL OF PINEAL RESEARCH 1.0 (55.0), pp. 58.0-64.0 |
64 | 0 | 0 | 0 | 0 | 0 | 64 | |
| 6. | A phase II randomized, double-blind placebo-controlled trial of an antiemetic, 6-gingerol in solid tumor patients receiving moderately to highly emetogenic adjuvant chemotherapy. | Jitprapa Konmun Kwanjit Danwilai Nuttapong Ngamphaiboon Aumkhae Sookprasert Ekaphop Sirachainan Suphat Subongkot |
2014 |
JOURNAL OF CLINICAL ONCOLOGY 15.0 (32.0), pp. |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 7. | ASSOCIATION BETWEEN HIGH PINEAL FLUORIDE CONTENT AND PINEAL CALCIFICATION IN A LOW FLUORIDE AREA | Trai Tharnpanich Jeffrey Johns Suphat Subongkot Nutjaree Pratheepawanit Johns Amnat Kitkhuandee Yanyong Toomsan Somkiat Luengpailin |
2016 |
FLUORIDE 4.0 (49.0), pp. 472.0-484.0 |
6 | 0 | 0 | 0 | 0 | 0 | 6 | |
| 8. | Hospitalization and cost after switching from atypical to typical antipsychotics in schizophrenia patients in Thailand | Tuanthon Boonlue Suphat Subongkot Piyameth Dilokthornsakul Ronnachai Kongsakon Oraluck Pattanaprateep Orabhorn Suanchang Nathorn Chaiyakunapruk |
2016 |
CLINICOECONOMICS AND OUTCOMES RESEARCH (8.0), pp. 127.0-136.0 |
4 | 0 | 0 | 0 | 0 | 0 | 4 | |
| 9. | Antioxidant activity of ginger extract as a daily supplement in cancer patients receiving adjuvant chemotherapy: a pilot study | Kwanjit Danwilai Jitprapa Konmun Bung-orn Sripanidkulchai Suphat Subongkot |
2017 |
CANCER MANAGEMENT AND RESEARCH (9.0), pp. 11.0-18.0 |
56 | 0 | 0 | 0 | 0 | 0 | 56 | |
| 10. | A phase II randomized double-blind placebo-controlled study of 6-gingerol as an anti-emetic in solid tumor patients receiving moderately to highly emetogenic chemotherapy | J. Konmun K. Danwilai N. Ngamphaiboon B. Sripanidkulchai A. Sookprasert S. Subongkot |
2017 |
MEDICAL ONCOLOGY 4.0 (34.0), pp. |
56 | 0 | 0 | 0 | 0 | 0 | 56 | |
| 11. | Beneficial Effects of Adjuvant Melatonin in Minimizing Oral Mucositis Complications in Head and Neck Cancer Patients Receiving Concurrent Chemoradiation | Kittipong Onseng Nutjaree Pratheepawanit Johns Thanut Khuayjarernpanishk Suphat Subongkot Aroonsri Priprem Cameron Hurst Jeffrey Johns |
2017 |
JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE 12.0 (23.0), pp. 957.0-963.0 |
54 | 0 | 0 | 0 | 0 | 0 | 54 | |
| 12. | Comparative efficacy and safety of pharmacologic interventions for cachexia: A systematic review and network meta-analysis | M. Sae-Teaw S. Subongkot N. Chaiyakunapruk |
2017 |
ANNALS OF ONCOLOGY (28.0), pp. 155.0-155.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 13. | Translation and validation of the Thai version of Family Reported Outcome Measure (Thai FROM-16VC) in Thai family members of cancer patients | S. Subongkot P. Chantarasap N. P. Johns S. Pairojkul A. Sookprasert |
2017 |
ANNALS OF ONCOLOGY (28.0), pp. |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 14. | Cost-effectiveness analysis of olanzapine-containing antiemetic therapy for managing highly emetogenic chemotherapy in Southeast Asia: a multinational study | Suthan Chanthawong Yi Heng Lim Suphat Subongkot Alexandre Chan Rizka Andalusia Ros Suzanna Ahmad Bustamam Nathorn Chaiyakunapruk |
2019 |
SUPPORTIVE CARE IN CANCER 3.0 (27.0), pp. 1109.0-1119.0 |
19 | 0 | 0 | 0 | 0 | 0 | 19 | |
| 15. | Validation of the Thai version of the family reported outcome measure (FROM-16)(c) to assess the impact of disease on the partner or family members of patients with cancer | Pattariya Chantarasap Nutjaree Pratheepawanit Johns Srivieng Pairojkul Aumkhae Sookprasert Kosin Wirasorn Areewan Cheawchanwattana Sam Salek Suphat Subongkot |
2019 |
HEALTH AND QUALITY OF LIFE OUTCOMES (17.0), pp. |
5 | 0 | 0 | 0 | 0 | 0 | 5 | |
| 16. | Doripenem Pharmacokinetics in Hemodialysis | Sirin Phenphinan Aporanee Chaiyakum Suphat Subongkot Chantana Aromdee Porpon Rotjanapan Montira Assanatham Siriluk Jaisue |
2020 |
INFECTIOUS DISEASES IN CLINICAL PRACTICE 4.0 (28.0), pp. 216.0-222.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 17. | HLA-DRB1*07:01 and lapatinib-induced hepatotoxicity: a systematic review and meta-analysis | Wimonchat Tangamornsuksan Chuenjid Kongkaew C. N. Scholfield Suphat Subongkot Manupat Lohitnavy |
2020 |
PHARMACOGENOMICS JOURNAL 1.0 (20.0), pp. 47.0-56.0 |
6 | 0 | 0 | 0 | 0 | 0 | 6 | |
| 18. | An Exploration of Heart Failure Risk in Breast Cancer Patients Receiving Anthracyclines with or without Trastuzumab in Thailand: A Retrospective Study | Jukapun Yoodee Aumkhae Sookprasert Phitjira Sanguanboonyaphong Suthan Chanthawong Manit Seateaw Suphat Subongkot |
2021 |
CLINICS AND PRACTICE 3.0 (11.0), pp. 484.0-493.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 19. | Efficacy and safety of pharmacological cachexia interventions: systematic review and network meta-analysis | Manit Saeteaw Phitjira Sanguanboonyaphong Jukapun Yoodee Kaitlyn Craft Ratree Sawangjit Nuttapong Ngamphaiboon Prapimporn Chattranukulchai Shantavasinkul Suphat Subongkot Nathorn Chaiyakunapruk |
2021 |
BMJ SUPPORTIVE & PALLIATIVE CARE 1.0 (11.0), pp. 75.0-85.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Title | Authors | Year | Journal title | ||
|---|---|---|---|---|---|
| 1. | Exploration the Results of Cancer Pain Management Following Implementation of World Health Organization (WHO) Pain Guideline | Suphat Subongkot Sugunya Khounnikhom Nutjaree Pratheepawanit Johns Aunkhae Sookprasert |
2008 |
Isan Journal of Pharmaceutical Sciences (4 No 1), pp. 77-96 |
|
| 2. | Outcome of Chemotherapy Counseling in Oncology Patients by Pharmacist | Suphat Subongkot Siriwan Srisawat Nutjaree Pratheepawanit Johns Aunkhae Sookprasert |
2009 |
Isan Journal of Pharmaceutical Sciences (5 No 1), pp. 34-45 |
|
| 3. | Cachexia: A Review of Therapeutic and Management | Suphat Subongkot Thailand. Khon Kaen Kittipong Onseng |
2012 |
Isan Journal of Pharmaceutical Sciences (8 No 1), pp. 1-14 |
|
| 4. | Drug Use Review of Olanzapine for Psychiatric Outpatients at Srinagarind Hospital | Suthan Chanthawong Pattharee Paholpak Samai Junnamom Suphat Subongkot Denpong Patthanasetthanon Wilaiwan Boontawee Amornrat Shoora Suchat Paholpak |
2012 |
Journal of the Psychiatric Association of Thailand (57 No 4), pp. 447-454 |
|
| 5. | คุณภาพชีวิตของผู้ป่วยมะเร็งเต้านมระยะต้นและระยะลุกลาม | สุภัสร์ สุบงกช นุจรี ประทีปปะวณิช จอห์นส อรไพลิน เผื่อนพินิจ หทัยกาญจน์ สายทรัพย์ กัญญาณัฐ เนตรสถิตย์ |
2014 |
Isan Journal of Pharmaceutical Sciences (9 No 3), pp. 175 |
|
| 6. | Evaluation of Chemotherapy Contamination Following the Implementation of Closed System Transfer Devices | Warunsuda Sripakdee Suphat Subongkot Wannaporn Wattanawong Saroch Onlaor |
2015 |
Applied Environmental Research (37 No 1), pp. 83-91 |
| Title | Authors | NRIIS type | Year | NRIIS Scholarship |
|---|